Yahoo
Jakarta - Delayed Quote IDR

PT Metro Healthcare Indonesia Tbk (CARE.JK)

356.00 -22.00 (-5.82%)
At close: 4:00:04 PM GMT+7
Chart Range Bar
Loading chart for CARE.JK
  • Previous Close 378.00
  • Open 382.00
  • Bid 356.00 x --
  • Ask 366.00 x --
  • Day's Range 356.00 - 382.00
  • 52 Week Range 278.00 - 965.00
  • Volume 279,600
  • Avg. Volume 42,238,541
  • Market Cap (intraday) 11.837T
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 1,695.24
  • EPS (TTM) 0.21
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides healthcare activities and physical treatment, outpatient, inpatient managed by private hospitals; manages business consulting and activities, sells laboratory equipment, pharmaceuticals, and medical devices; undertakes hospital activities, and retail trade of pharmaceutical products at pharmacies. It also offers management consulting services; and operates private polyclinics. The company was founded in 2015 and is based in Tangerang, Indonesia.

www.metrohealthcareindonesia.co.id

881

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

CARE.JK
47.65%
IDX COMPOSITE (^JKSE)
43.28%

1-Year Return

CARE.JK
9.88%
IDX COMPOSITE (^JKSE)
40.73%

3-Year Return

CARE.JK
74.51%
IDX COMPOSITE (^JKSE)
27.76%

5-Year Return

CARE.JK
22.27%
IDX COMPOSITE (^JKSE)
25.15%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.20%

  • Return on Assets (ttm)

    1.61%

  • Return on Equity (ttm)

    0.24%

  • Revenue (ttm)

    571.05B

  • Net Income Avi to Common (ttm)

    6.83B

  • Diluted EPS (ttm)

    0.21

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    961.66B

  • Total Debt/Equity (mrq)

    51.23%

  • Levered Free Cash Flow (ttm)

    -200.96B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: